BU-NOT-SET

CONTACT US
Post-Brexit medicines - stuck in the UK?
  • Industry trends
Eyes
Insight
Brexit: What will it mean for the regulation of medicines?
  • Industry trends
Eyes
Insight
Stability study trends - Outsourcing stability studies
  • Analytical chemistry
Eyes
Insight
The EMA relocation: Brexit and the UK's pharmaceutical industry
  • Industry trends
Eyes
Insight
Prevention not cure: avoiding a European prescription opioid epidemic
  • Drug product
Eyes
Insight
Six months and counting: industry views
  • Manufacturing
Eyes
Insight
Six months until DSCSA… industry comments
  • Manufacturing
Eyes
Insight
Ensuring serialisation success
  • Manufacturing
Eyes
Insight
Serialisation ready?
  • Manufacturing
Eyes
Insight
White paper
  • Biologics
  • Manufacturing
Advanced Bio is advancing rAAV production
White paper
  • Biologics
  • Manufacturing
Advanced Bio Is advancing LNP formulation
White paper
  • Drug product
  • Manufacturing
Optimising drug formulation: The critical role of granulation
Case study
  • Drug product
  • Manufacturing
Overcoming fixed-dose combination challenges for ALS
Video
  • Industry trends
What’s shaping the future of pharma?
Insight
  • Drug product
  • Manufacturing
Mastering tech-transfer: Turning complexity into competitive advantage
Insight
  • Drug product
  • Manufacturing
Four ways ReciPredict can transform your pharma manufacturing
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How lyophilisation can help overcome mRNA stability challenges